EBITDA Margin ratio Analysis of Cyclacel Pharmaceuticals Inc - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-6342.42
Period Ending - Dec-22
Very Poor EBITDA Margin
-4409.92
Growth
-43.82 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-26177.38
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-25096.55
EBITDA Margin Analysis of Cyclacel Pharmaceuticals Inc
Ebitda Margin Ratio of Cyclacel Pharmaceuticals Inc with value of -26177.38 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Cyclacel Pharmaceuticals Inc with value of -25096.55 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of CYCC drastically fell by -43.82 % this year. |
EBITDA Margin Ratio with value of 0 was highest in Year Dec-21 in last Five Years. |
EBITDA Margin Ratio with value of -164386.59 was lowest in Year Dec-20 in last Five Years. |
Latest EBITDA Margin Ratio with value of -6342.42 is Greater than Average EBITDA Margin of -35027.79 in last five years. |
Ebitda Margin of Cyclacel Pharmaceuticals Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of CYCC that may interest you.
Cyclacel Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
CYCC | 2.64 | 2.02 | 30.69 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Cyclacel Pharmaceuticals Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
EBITDA Margin | -6342.42 | -4409.92 | 0 | -164386.59 | 0 | -5730.67 | 0 |
Change | -43.82 % | 0 % | 0 % | 0 % |
FY Chart of EBITDA Margin of Cyclacel Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)